FDA greenlights first human trial of age-reversal gene therapy
Dr_Singularity · x · 2026-11-23
Per a viral post, the FDA has reportedly greenlit the first human trial of an age-reversal gene therapy. DrSingularity comments that despite many crazy breakthroughs happening at once, this may still be the slowest, most uneventful chapter of the future ahead. Details are third-hand and unverified, but it would be a landmark moment for longevity research if confirmed.
More from AGI Musings
- Uber burned its annual AI budget in 4 months with no visible improvement — yaroslavvb · 2026-11-23
- Post-training may exceed 75% of FLOPs, undercutting perplexity-based safety bars — stochasticchasm · 2026-11-23
- Gary Marcus doubles down: calling out overhyped LLM capabilities is engineering rigor — GaryMarcus · 2026-11-23
- AI safety researcher slams doxxing in the community: don't burn the commons on turn one — sjgadler · 2026-11-23
- AI proofs are a different kind of brute force: fast enough to skip inventing new math — moultano · 2026-11-23
- Google researcher: AI proofs skip human-style cleverness via speed and knowing all of math — moultano · 2026-11-23